Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Jamaican Castor Oil for far more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
9
uses studied
12
papers cited
0
hidden from you
What the published studies found
Traditional · 2 studies
Eczema
Both retrieved studies are ethnobotanical surveys documenting traditional use of Ricinus communis (castor) preparations for skin diseases, including eczema, in Nigerian and Indian Tharu communities. Neither provides clinical, controlled, or laboratory evidence evaluating castor oil's efficacy for eczema; traditional use is the only support found.
The retrievable evidence consists of an ethnopharmacological survey documenting traditional use of Ricinus communis (castor) for pain management in Mauritius and a narrative review attributing analgesic/anti-inflammatory properties to the castor plant. No RCTs, systematic reviews, or human clinical trials evaluating Jamaican castor oil specifically for muscle pain were identifiable among the results.
No human clinical studies support Jamaican castor oil for sleep or insomnia. The only marginally relevant finding is a preclinical mouse study (PMID 29576059) showing that two isolated Ricinus communis sesquiterpenes (not the oil itself) reduced locomotor activity in an open-field test, a proxy for sedation; the second paper (PMID 40157249) is an Ayurvedic case report on venous leg ulcer where 'sleep disturbance' appears only as a symptom of the ulcer, not as a treatment target.
The only relevant publication is a 2026 narrative review of castor oil in dermatology that tags acne as a keyword but presents no clinical evidence that castor oil treats acne; its only acne-related connection is castor oil's use as a penetration-enhancing vehicle in adapalene microemulsion formulations. Documented benefits in the review concern hair luster, androgenic alopecia, hyperpigmentation, and hydration—not acne.
Of the 16 PMIDs returned, the fully assessable record (PMID 41573499, a 2025 narrative review) shows Ricinus communis has in-vitro antimicrobial, anti-inflammatory, and antioxidant activity relevant to wound pathogens (e.g., S. aureus, P. aeruginosa), but this evidence is based mainly on leaf extracts rather than castor seed oil, and no human clinical trials for burns or wound healing were identified.
A single ethnobotanical survey documented that the Tharu community of Uttarakhand, India, uses Ricinus communis (castor) as its most preferred plant for skin diseases, with dandruff among the conditions treated with local plant remedies (3 species). However, the abstract does not confirm castor was used specifically for dandruff, and no clinical trials, controlled studies, or in-vitro experiments testing castor oil against dandruff were identified.
The only relevant evidence identified is an ethnobotanical review documenting that Ricinus communis (castor) is among the most commonly cited traditional remedies for pain and inflammatory conditions, including headache, in South African folk medicine. No clinical trials, pharmacological studies, or mechanistic research evaluating castor oil specifically for headache or migraine were found.
The only direct clinical evidence is a small exploratory single-arm trial (no control group) suggesting castor oil cream may reduce infraorbital hyperpigmentation, summarized in a 2026 narrative review; a melasma study used a phenol peel merely modified with castor oil, and a pigmentation study used hydrogenated castor oil only as a delivery vehicle for resveratrol. No RCTs, systematic reviews, or studies on Jamaican (black) castor oil specifically exist for hyperpigmentation.
Of the 21 PubMed results, only one study directly tested Ricinus communis (castor) for joint disease: in a collagenase-induced osteoarthritis rat model, oral castor plant powder (one of six herbs tested) significantly reduced knee swelling, paw volume, and cartilage damage, though it was not the most potent herb in the study (Sida cordifolia and Piper longum performed best). No human clinical trials were found; most other retrieved papers (e.g., PMIDs 1512760, 8228286) merely use Ricinus communis agglutinin (ricin/RCA-1) as a laboratory reagent in arthritis biomarker research, not as a treatment.
